ES2040394T3 - Procedimiento para preparar un material liofilizado de ifosfamida y mesna. - Google Patents

Procedimiento para preparar un material liofilizado de ifosfamida y mesna.

Info

Publication number
ES2040394T3
ES2040394T3 ES198989103844T ES89103844T ES2040394T3 ES 2040394 T3 ES2040394 T3 ES 2040394T3 ES 198989103844 T ES198989103844 T ES 198989103844T ES 89103844 T ES89103844 T ES 89103844T ES 2040394 T3 ES2040394 T3 ES 2040394T3
Authority
ES
Spain
Prior art keywords
mesna
ifosfamide
preparing
procedure
lyophilized material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989103844T
Other languages
English (en)
Inventor
Dieter Sauerbier
Otto Dr. Isaac
Wolfgang Peter Dr. Brade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2040394T3 publication Critical patent/ES2040394T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Control Of El Displays (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LIOFILIZADO DE IFOSFAMIDA - MESNA, COMPUESTO ESENCIALMENTE POR IFOSFAMIDA, 0,1 - 1,0 PARTES DEL PESO DE MESNA Y 0,1 A 17 PARTES DEL PESO DE HEXITA.
ES198989103844T 1988-03-19 1989-03-04 Procedimiento para preparar un material liofilizado de ifosfamida y mesna. Expired - Lifetime ES2040394T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3809337 1988-03-19

Publications (1)

Publication Number Publication Date
ES2040394T3 true ES2040394T3 (es) 1993-10-16

Family

ID=6350216

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989103844T Expired - Lifetime ES2040394T3 (es) 1988-03-19 1989-03-04 Procedimiento para preparar un material liofilizado de ifosfamida y mesna.

Country Status (11)

Country Link
US (1) US4959215A (es)
EP (1) EP0334083B1 (es)
JP (1) JP2865698B2 (es)
AT (1) ATE65402T1 (es)
CA (1) CA1326452C (es)
DE (1) DE58900183D1 (es)
ES (1) ES2040394T3 (es)
FI (1) FI89456C (es)
GR (1) GR3002377T3 (es)
IE (1) IE60721B1 (es)
PT (1) PT90030B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59101431D1 (de) * 1990-07-16 1994-05-26 Asta Medica Ag Tablette und Granulat welche als Wirkstoff Mesna enthalten.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
DE4233842A1 (de) * 1992-10-08 1994-04-14 Asta Medica Ag Mesna Injektionslösungen
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
CA2497898C (en) * 2002-09-05 2012-02-07 Bharat Serums & Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
CN100463678C (zh) * 2002-12-02 2009-02-25 印度血清及疫苗有限公司 用于肠胃外给药的异环磷酰胺组合物及其制备方法
US20070192947A1 (en) * 2003-07-10 2007-08-23 Cylena Medical Technologies Inc. Protective apparel with improved doffing
US8093230B2 (en) * 2003-10-01 2012-01-10 Baxter International Inc. Supersaturated aqueous ifosfamide compositions
EP1799266A2 (en) * 2004-09-13 2007-06-27 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
WO2010010383A1 (en) * 2008-07-21 2010-01-28 Isis Innovation Limited Treatment of obesity
AU2010218109B2 (en) * 2009-02-24 2015-04-09 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
US10092312B2 (en) * 2013-05-07 2018-10-09 Auxin Surgery Sa Device for chemically assisted dissection
EP3092009B1 (en) 2014-01-06 2019-08-14 AuXin Surgery SA Lyophilized mesna compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002495B1 (de) * 1977-12-14 1984-02-15 Asta-Werke Aktiengesellschaft Chemische Fabrik Erzeugnisse zur Anwendung in der cytostatischen Therapie
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4859452A (en) * 1986-01-17 1989-08-22 Board Of Regents, The University Of Texas System Methods for the reduction of difluoromethylornithine associated toxicity
DE3768419D1 (de) * 1986-10-07 1991-04-11 Boehringer Biochemia Srl Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
NO873860L (no) * 1986-10-31 1988-05-02 Asta Pharma Ag Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.

Also Published As

Publication number Publication date
IE60721B1 (en) 1994-08-10
CA1326452C (en) 1994-01-25
JP2865698B2 (ja) 1999-03-08
JPH024796A (ja) 1990-01-09
FI89456C (fi) 1993-10-11
PT90030B (pt) 1994-05-31
IE890854L (en) 1989-09-19
FI891283A0 (fi) 1989-03-17
GR3002377T3 (en) 1992-12-30
ATE65402T1 (de) 1991-08-15
DE58900183D1 (de) 1991-08-29
FI891283L (fi) 1989-09-20
EP0334083B1 (de) 1991-07-24
PT90030A (pt) 1989-11-10
FI89456B (fi) 1993-06-30
EP0334083A1 (de) 1989-09-27
US4959215A (en) 1990-09-25

Similar Documents

Publication Publication Date Title
ES2040394T3 (es) Procedimiento para preparar un material liofilizado de ifosfamida y mesna.
MX16158A (es) Un procedimiento para la preparacion de derivados aromaticos y heterociclicos de carboxiamida, utiles como agentes antitumorales
AR008680A1 (es) Substitutos de plaquetas y metodos de conjugacion apropiados para su preparacion
ES2053816T3 (es) Liberacion prolongada de somatotropina.
SE8501709D0 (sv) Improvements in or relating to intrleukin therapy
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
DE3872711D1 (de) Synthetisches knieband.
ATE28029T1 (de) Brustprothese.
FR2452915B1 (fr) Prothese tibiale
DK474888A (da) Fugtighedshaerdeligt en-dels-urethanmateriale
ES2196149T3 (es) Preparaciones purgantes no acuosas para el colon.
ES552344A0 (es) Procedimiento para la fabricacion de un material para proporcionar articulos polimericos fundidos
DE3667996D1 (de) Farbige siliconmassen.
ES2017982B3 (es) Liofilizado de ifosfamida y procedimiento para su preparacion.
MX10428A (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y productos obtenidos mediante el mismo.
ES548492A0 (es) Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion
BR8805459A (pt) Ponta de protecao para a armacao de um artigo de vestuario
MX167284B (es) , "procedimiento mejorado para tratar a la flama filamentos termoplasticos
IT1217315B (it) Composti triazinici derivati dalla 2,2,6,6-tetrametilpiperidina
ES2012333B3 (es) Aguja de lengueta para maquinas textiles y procedimiento par su fabricacion
MX7221E (es) Procedimiento para la preparacion de derivados de los acidos 2 o 4 tiazolidincarboxilicos 3-acil sustituidos
ES2054629T3 (es) Mezcla polimerica de alta tenacidad y alta flexibilidad.
DK184685D0 (da) Fenoldopam-4',8-bis-hydrogensulfater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
AR230619A1 (es) Procedimiento para la preparacion de 2-naftalenoetanimidamida n,n'-disustituida e intermediarios utilizados en el mismo
ES512945A0 (es) "procedimiento para la confeccion de prendas elasticas de malla".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 334083

Country of ref document: ES